Apr 25 |
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
|
Apr 24 |
Hookipa to receive $10M from Roche as FDA clears cancer trial
|
Apr 24 |
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
|
Apr 24 |
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
|
Apr 22 |
Hookipa Pharma: 04/25/24 Update Should Be The First Of Several Positive Catalysts
|
Apr 16 |
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
|
Apr 10 |
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
|
Mar 24 |
Time To Worry? Analysts Just Downgraded Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Outlook
|
Mar 22 |
HOOKIPA Pharma Inc. (HOOK) Reports Q4 Loss, Tops Revenue Estimates
|
Mar 22 |
HOOKIPA Pharma GAAP EPS of -$0.22 misses by $0.02, revenue of $7.41M beats by $2.85M
|